Healthy chinese volunteers test new drug remternetug in early safety study
NCT ID NCT07346495
First seen Jan 19, 2026 · Last updated May 25, 2026 · Updated 22 times
Summary
This early-stage study is testing a single dose of the drug remternetug in 24 healthy Chinese adults to see if it is safe and how the body processes it. Participants receive the drug as an injection under the skin and are monitored for about 25 weeks. The study does not aim to treat any disease, but to gather important safety and drug-level information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Shanghai Xuhui Central Hospital
Xuhui District, 20031, China
-
Xuanwu Hospital Capital Medical University
Beijing, 100053, China
Conditions
Explore the condition pages connected to this study.